BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fucoidan {Brown Algae Extract} - Escherichia coli 1-250-04_S1_C2 |
👶
Effect of maternal seaweed extract supplementation on suckling piglet growth, humoral immunity, selected microflora, and immune response after an ex vivo lipopolysaccharide challenge. Journal of animal science (J Anim Sci ) Vol: 90 Issue 2 Pages: 505-14 Pub: 2012 Feb Epub: 2011 Sep 23 Authors Leonard SG , Sweeney T , Bahar B , O'Doherty JV , Publication |
| fucoidan {Brown Algae Extract} - Escherichia coli 1-250-04_S1_C2 |
👶
Effect of dietary laminarin and fucoidan on selected microbiota, intestinal morphology and immune status of the newly weaned pig. The British journal of nutrition (Br J Nutr ) Vol: 110 Issue 9 Pages: 1630-8 Pub: 2013 Nov 14 Epub: 2013 Mar 26 Authors Walsh AM , Sweeney T , O'Shea CJ , Doyle DN , O'Doherty JV , Publication |
| fucoidan {Brown Algae Extract} - Escherichia coli 1-250-04_S1_C2 |
👶
The effect of dietary laminarin and fucoidan in the diet of the weanling piglet on performance, selected faecal microbial populations and volatile fatty acid concentrations. Animal : an international journal of animal bioscience (Animal ) Vol: 4 Issue 4 Pages: 579-85 Pub: 2010 Apr Epub: Authors McDonnell P , Figat S , O'Doherty JV , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
